Right, but why should any smart investor keep their money in a company who plans to dilute, reverse split, etc. when a decision on their bread and butter drug is still more than a year away?
No one is arguing whether or not the drugs are exciting. The problem is all of the financial hurdles the company will have to clear at the expense of the shareholders to get them to market.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.